1. Home
  2. BHVN vs SCL Comparison

BHVN vs SCL Comparison

Compare BHVN & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • SCL
  • Stock Information
  • Founded
  • BHVN 2013
  • SCL 1932
  • Country
  • BHVN United States
  • SCL United States
  • Employees
  • BHVN N/A
  • SCL N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • SCL Package Goods/Cosmetics
  • Sector
  • BHVN Health Care
  • SCL Consumer Discretionary
  • Exchange
  • BHVN Nasdaq
  • SCL Nasdaq
  • Market Cap
  • BHVN 1.1B
  • SCL 988.9M
  • IPO Year
  • BHVN 2017
  • SCL N/A
  • Fundamental
  • Price
  • BHVN $8.29
  • SCL $44.11
  • Analyst Decision
  • BHVN Strong Buy
  • SCL
  • Analyst Count
  • BHVN 16
  • SCL 0
  • Target Price
  • BHVN $37.07
  • SCL N/A
  • AVG Volume (30 Days)
  • BHVN 5.6M
  • SCL 211.5K
  • Earning Date
  • BHVN 11-10-2025
  • SCL 10-29-2025
  • Dividend Yield
  • BHVN N/A
  • SCL 3.58%
  • EPS Growth
  • BHVN N/A
  • SCL N/A
  • EPS
  • BHVN N/A
  • SCL 1.98
  • Revenue
  • BHVN N/A
  • SCL $2,303,837,000.00
  • Revenue This Year
  • BHVN N/A
  • SCL $8.89
  • Revenue Next Year
  • BHVN $2,079.03
  • SCL $8.97
  • P/E Ratio
  • BHVN N/A
  • SCL $22.32
  • Revenue Growth
  • BHVN N/A
  • SCL 5.35
  • 52 Week Low
  • BHVN $7.48
  • SCL $41.82
  • 52 Week High
  • BHVN $50.40
  • SCL $79.12
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 29.46
  • SCL 45.22
  • Support Level
  • BHVN $7.48
  • SCL $43.60
  • Resistance Level
  • BHVN $8.77
  • SCL $45.35
  • Average True Range (ATR)
  • BHVN 1.12
  • SCL 1.39
  • MACD
  • BHVN -0.71
  • SCL 0.22
  • Stochastic Oscillator
  • BHVN 7.26
  • SCL 56.34

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

Share on Social Networks: